CINQAIR (RESLIZUMAB) — FDA Approval BLA761033 (TEVA RESPIRATORY LLC)
CINQAIR (RESLIZUMAB) — FDA Approval BLA761033 (TEVA RESPIRATORY LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CINQAIR; Active ingredients: RESLIZUMAB; Application number: BLA761033.
| Brand name | CINQAIR |
|---|---|
| Active ingredients | RESLIZUMAB |
| Application number | BLA761033 |
| Sponsor | TEVA RESPIRATORY LLC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20160323 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →